KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
000919 Jinling Pharmaceutical
- 7.14
- -0.13-1.79%
Market Closed Dec 13 15:00 CST
4.45BMarket Cap60.51P/E (TTM)
7.29High7.12Low138.24KlotVolume7.26Open7.27Pre Close99.39MTurnover2.34%Turnover Ratio44.63P/E (Static)623.71MShares8.7752wk High1.18P/B4.22BFloat Cap5.2852wk Low8.00Limit Up590.36MShs Float29.05Historical High6.54Limit Down2.34%Amplitude0.09Historical Low0.10Dividend TTM7.19Avg Price83.86KlotAsk1.40%Div YieldTTM100Lot Size54.30KlotBid
Jinling Pharmaceutical News
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on the completion of the liquidation and cancellation of its wholly-owned subsidiary
Jinling Pharmaceutical: Legal Opinion of Jiangsu Taihe Law Firm on the 2024 Fourth Extraordinary General Meeting of Shareholders of Jinling Pharmaceutical Co., Ltd.
Jinling Pharmaceutical: Announcement of Resolutions of the 2024 Fourth Extraordinary General Meeting of Shareholders of Jinling Pharmaceutical Co., Ltd.
Jinling Pharmaceutical: Prompt Announcement of Jinling Pharmaceutical Co., Ltd. on the holding of the 4th Extraordinary General Meeting of Shareholders in 2024
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on the progress of the company and its subsidiaries using idle own funds to purchase wealth management products
Jinling Pharmaceutical: Nanjing Xingong Investment Group Co., Ltd. plans to transfer the asset evaluation report of part of the Nanjing Xingong Medical Industry Investment Fund Partnership (Limited Partnership) fund share project held by Nanjing Xingong Medical Industry Investment Group Co., Ltd. to Jinling Pharmaceutical Co., Ltd.
Jinling Pharmaceutical: Notice of Jinling Pharmaceutical Co., Ltd. on convening the 4th Extraordinary General Meeting of Shareholders in 2024
Jinling Pharmaceutical: Announcement by Jinling Pharmaceutical Co., Ltd. on the progress of litigation involving the holding subsidiary\'s performance commitment compensation
Jinling Pharmaceutical: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders of Jinling Pharmaceutical Co., Ltd.
Jinling Pharmaceutical: Legal Opinion of Jiangsu Taihe Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Jinling Pharmaceutical Co., Ltd.
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on the repurchase and cancellation of some restricted shares, reduction of registered capital and notification to creditors
Jinling Pharmaceutical: Prompt Announcement of Jinling Pharmaceutical Co., Ltd. on the holding of the 3rd Extraordinary General Meeting of Shareholders in 2024
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on the progress of the company and its subsidiaries using idle own funds to purchase wealth management products
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on changing the registered capital and amending the “Articles of Association”
Jinling Pharmaceutical: 2024 Semi-Annual Financial Report
Jinling Pharmaceutical: Semi-annual non-operating capital usage and other related capital transactions summary table
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on adjusting the positions of the company\'s senior management personnel and appointing an assistant to the company\'s president
Jinling Pharmaceutical: Notice of Jinling Pharmaceutical Co., Ltd. on convening the 3rd Extraordinary General Meeting of Shareholders in 2024
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. Regarding Control Subsidiary Received Notice of Approval for Chemical Raw Material Drug Listing Application
Jinling Pharmaceutical: Announcement on the Resignation of Non-Employee Supervisors of Jinling Pharmaceutical Co., Ltd.
